Eurofins

Biologiste Médical - Biologie des Hémopathies Malignes - F/H

Lyon, Auvergne-Rhône-Alpes, FR

In-personFull time roleEarly Career, Mid Level

13 days ago

About the Job

Dans le cadre de la croissance de nos activités de cytogénétique et de biologie moléculaire (NGS), nous recherchons un(e) :

Biologiste Médecin ou Pharmacien.ne en CDI – Spécialisé.e en biologie des hémopathies malignes - F/H

Vos missions seront les suivantes :

Validation biologique des analyses de NGS Somatique (panels NGS myéloïdes et lymphoïdes) et de cytogénétique acquise ;
Participation aux projets d’innovation menés dans le laboratoire et développement de nouvelles analyses en collaboration avec les cadres scientifiques ;
Participation à la démarche d’Assurance Qualité ;
Communications scientifiques (participation aux congrès, EPU) ;
Participation aux sociétés savantes.

About the Company

Eurofins

Luxembourg, Luxembourg

5000 +

<div class="org-about-module__description"> <div id="ember58" class="ember-view organization-about-module__content-consistant-cards-description"><span class="lt-line-clamp__raw-line">Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins is a global leader in food, environmental, pharmaceutical and cosmetic product testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies. Since 1987, Eurofins has grown from one laboratory in Nantes, France to ca. 62,000 staff across a network of independent companies in 62 countries, operating over 900 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.</span></div> </div> <div class="org-about-module__content-improvement"> <div class="org-about-module__content-box"> </div> </div>